Abstract 301P
Background
This study aimed to investigate the clinical implications of desaturation during the 6-min walk test (6MWT) for postoperative cardiopulmonary complications in non-small cell lung cancer (NSCLC) patients with moderately decreased lung function.
Methods
Between January 2010 and December 2019, 312 patients whose predicted postoperative value of forced expiratory volume in 1 second (ppoFEV1) or diffusing capacity of carbon monoxide (ppoDLco) were <60% while both were ≥ 30% and who had undergone lobectomy for NSCLC without induction treatment were included this study. Patients were classified into two groups based on the presence of oxygen desaturation (SpO2 <90%) during the 6MWT, and the prevalence and risk of cardiopulmonary complications were evaluated.
Results
Overall, 39 (12.5%) patients desaturated during the 6MWT. The prevalence of cardiopulmonary complications (48.7%, p = 0.007) and pulmonary complications (33.3%, p = 0.017) was significantly higher in patients who desaturated during the 6MWT than in those who did not. However, there was no significant difference in the incidence of postoperative cardiac complications between the two groups. In multivariable-adjusted analyses, the adjusted odds ratio for postoperative cardiopulmonary complications in patients who desaturated during the 6MWT was 2.34 (95% confidence interval = 1.16–4.75) compared to those who did not.
Conclusions
Oxygen desaturation during the 6MWT significantly increased the risk of post-lobectomy cardiopulmonary complications among lung cancer patients with moderately decreased lung function. Our study suggests that oxygen desaturation during the 6WMT could provide additional information when stratifying the postoperative surgical risks in NSCLC patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
283P - Comparative analysis of osteoporotic fracture (OF) and pathologic fracture (PF) in patients with metastatic colorectal cancer (mCRC) who received palliative chemotherapy
Presenter: Yejee Lim
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
287P - Long-term yoga enhances the quality of life and symptomatic scale in breast cancer patients undergoing treatment
Presenter: Mayank Jain
Session: Poster viewing 04
288P - Impact of hormonal contraception on estradiol and progesterone serum levels: A 6-year study on progression-free survival, disease-free survival, and overall survival at Dr. Moewardi Hospital
Presenter: Widyanti Soewoto
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04